Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

BioVendor Benefits from Using SCIENION’s Integrated Product Portfolio

Published: Tuesday, July 09, 2013
Last Updated: Tuesday, July 09, 2013
Bookmark and Share
Combined sciDROP PICO and sciDROP NANO technologies used for developing multiplex tests in microtiter plates.

SCIENION AG and BioVendor Laboratorni medicina a.s. have announced that BioVendor is using SCIENION’s complementary product portfolio for the production and detection of immunoassays.

Czech Republic Brno-based BioVendor Laboratorni medicina a.s. produces and distributes medical equipment and medical research products for international markets.

In its Research & Diagnostics Products division, BioVendor focuses on developing and manufacturing in vitro diagnostic and research-use only immunoassays, antibodies and recombinant proteins.

The company has begun developing its immunoassays using SCIENION’s integrated product portfolio including consumables such as sciPLEXPLATES, the sciFLEXARRAYER dispenser configured with both sciPICO and the new sciDROP NANO option, as well as the sciREADER CL for detection of assay results.

Dr. Viktor Růžička, CEO of BioVendor Laboratorni medicina a.s., comments: “Miniaturization and automation are key to our immunoassay production and the sciFLEXARRAYER has proven itself to be a state-of-the-art instrument for precise low volume liquid handling. We use it for developing new multiplex tests in microtiter plates to offer our customers cost-effective tools for parallel analytics. First application examples are multiplex IVD tests for the detection of borrelia infections as borreliosis can become a severe disease if not diagnosed early.”

Růžička also mentions another reason for choosing SCIENION technology: “We are spotting sensitive biological materials such as antigens and antibodies. Temperature is one of the factors that can have an impact of the functionality of these molecules. For us it is an important benefit of the sciFLEXARRAYER that the spotting head does not produce heat - especially as we manufacture tests in large quantities. Furthermore, SCIENION offers a cooling unit for source plates and targets.”

And finally he appreciates that SCIENION provides complete solutions for the automated production and detection of immunoassays because this facilitates work flow and enables advanced performance as products optimally complement each other.

Dr. Holger Eickhoff, CEO of SCIENION AG, states: “BioVendor has become a leading manufacturer of immunoassays for a wide range of applications. The company is known for many innovative products that are unique to the market. We are very pleased that BioVendor has selected SCIENION equipment for assay development and production. From the very start of our collaboration, BioVendor utilizes almost the complete range of our integrated product portfolio. I am confident that this decision will pay off for the company.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Four Gut Bacteria Decrease Asthma Risk in Infants
New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Antibiotic Overuse Might be Why so Many People Have Allergies
The Centers for Disease Control and Prevention estimates that drug resistant bacteria cause 23,000 deaths and two million illnesses each year.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos